Advertisement
Research Article| Volume 240, ISSUE 2, P305-310, June 2015

A genetic risk score of 45 coronary artery disease risk variants associates with increased risk of myocardial infarction in 6041 Danish individuals

  • N.T. Krarup
    Correspondence
    Corresponding author. The Novo Nordisk Foundation Center for Basic Metabolic Research, Faculty of Health and Medical Sciences, University of Copenhagen, Universitetsparken 1, DK-2100 Copenhagen, Denmark.
    Affiliations
    The Novo Nordisk Foundation Center for Basic Metabolic Research, Section of Metabolic Genetics, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark
    Search for articles by this author
  • A. Borglykke
    Affiliations
    Research Center for Prevention and Health, Glostrup University Hospital, Glostrup, Denmark
    Search for articles by this author
  • K.H. Allin
    Affiliations
    The Novo Nordisk Foundation Center for Basic Metabolic Research, Section of Metabolic Genetics, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark
    Search for articles by this author
  • C.H. Sandholt
    Affiliations
    The Novo Nordisk Foundation Center for Basic Metabolic Research, Section of Metabolic Genetics, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark
    Search for articles by this author
  • J.M. Justesen
    Affiliations
    The Novo Nordisk Foundation Center for Basic Metabolic Research, Section of Metabolic Genetics, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark
    Search for articles by this author
  • E.A. Andersson
    Affiliations
    The Novo Nordisk Foundation Center for Basic Metabolic Research, Section of Metabolic Genetics, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark
    Search for articles by this author
  • N. Grarup
    Affiliations
    The Novo Nordisk Foundation Center for Basic Metabolic Research, Section of Metabolic Genetics, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark
    Search for articles by this author
  • T. Jørgensen
    Affiliations
    Research Center for Prevention and Health, Glostrup University Hospital, Glostrup, Denmark

    Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark

    Faculty of Medicine, University of Aalborg, Aalborg, Denmark
    Search for articles by this author
  • O. Pedersen
    Affiliations
    The Novo Nordisk Foundation Center for Basic Metabolic Research, Section of Metabolic Genetics, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark
    Search for articles by this author
  • T. Hansen
    Affiliations
    The Novo Nordisk Foundation Center for Basic Metabolic Research, Section of Metabolic Genetics, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark

    Faculty of Health Sciences, University of Southern Denmark, Odense, Denmark
    Search for articles by this author

      Highlights

      • This study extends the knowledge of genetic risk of coronary artery disease in Danes.
      • A genetic risk score of 45 CAD risk-variants associate with myocardial infarction.
      • The genetic risk score improves C-index but not reclassification by European SCORE risk factors.

      Abstract

      Background

      In Europeans, 45 genetic risk variants for coronary artery disease (CAD) have been identified in genome-wide association studies. We constructed a genetic risk score (GRS) of these variants to estimate the effect on incidence and clinical predictability of myocardial infarction (MI) and CAD.

      Methods

      Genotype was available from 6041 Danes. An unweighted GRS was constructed by making a summated score of the 45 known genetic CAD risk variants. Registries provided information (mean follow-up = 11.6 years) on CAD (n = 374) and MI (n = 124) events. Cox proportional hazard estimates with age as time scale was adjusted for sex, BMI, type 2 diabetes mellitus and smoking status. Analyses were also stratified either by sex or median age (below or above 45 years of age). We estimated GRS contribution to MI prediction by assessing net reclassification index (NRI) and integrated discrimination improvement (IDI) added to the European SCORE for 10-year MI risk prediction.

      Results

      The GRS associated significantly with risk of incident MI (allele-dependent hazard ratio (95%CI): 1.06 (1.02–1.11), p = 0.01) but not with CAD (p = 0.39). Stratification revealed association of GRS with MI in men (1.06 (1.01–1.12), p = 0.02) and in individuals above the median of 45.11 years of age (1.06 (1.00–1.12), p = 0.03). There was no interaction between GRS and gender (p = 0.90) or age (p = 0.83). The GRS improved neither NRI nor IDI.

      Conclusion

      The GRS of 45 GWAS identified risk variants increase the risk of MI in a Danish cohort. The GRS did not improve NRI or IDI beyond the performance of conventional European SCORE risk factors.

      Keywords

      Abbreviations:

      GRS (genetic risk score), CAD (coronary artery disease), MI (myocardial infarction), SNP (single-nucleotide polymorphism), SBP (systolic blood-pressure), DBP (diastolic blood-pressure)
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Atherosclerosis
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Mathers C.D.
        • Loncar D.
        Projections of global mortality and burden of disease from 2002 to 2030.
        PLoS Med. 2006; 3: e442
        • Conroy R.M.
        • Pyorala K.
        • Fitzgerald A.P.
        • et al.
        Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project.
        Eur. Heart J. 2003; 24: 987-1003
        • Hawe E.
        • Talmud P.J.
        • Miller G.J.
        • et al.
        Family history is a coronary heart disease risk factor in the Second Northwick Park Heart Study.
        Ann. Hum. Genet. 2003; 67: 97-106
        • Fischer M.
        • Broeckel U.
        • Holmer S.
        • et al.
        Distinct heritable patterns of angiographic coronary artery disease in families with myocardial infarction.
        Circulation. 2005; 111: 855-862
        • Zdravkovic S.
        • Wienke A.
        • Pedersen N.L.
        • et al.
        Heritability of death from coronary heart disease: a 36-year follow-up of 20 966 Swedish twins.
        J. Intern. Med. 2002; 252: 247-254
        • Welcome Trust Case Control, C
        Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls.
        Nature. 2007; 447: 661-678
        • McPherson R.
        • Pertsemlidis A.
        • Kavaslar N.
        • et al.
        A common allele on chromosome 9 associated with coronary heart disease.
        Science. 2007; 316: 1488-1491
        • Helgadottir A.
        • Thorleifsson G.
        • Manolescu A.
        • et al.
        A common variant on chromosome 9p21 affects the risk of myocardial infarction.
        Science. 2007; 316: 1491-1493
        • Samani N.J.
        • Erdmann J.
        • Hall A.S.
        • et al.
        Genomewide association analysis of coronary artery disease.
        N. Engl. J. Med. 2007; 357: 443-453
        • Erdmann J.
        • Grosshennig A.
        • Braund P.S.
        • et al.
        New susceptibility locus for coronary artery disease on chromosome 3q22.3.
        Nat. Genet. 2009; 41: 280-282
        • Myocardial Infarction Genetics, C
        • Kathiresan S.
        • Voight B.F.
        • et al.
        Genome-wide association of early-onset myocardial infarction with single nucleotide polymorphisms and copy number variants.
        Nat. Genet. 2009; 41: 334-341
        • Schunkert H.
        • Konig I.R.
        • Kathiresan S.
        • et al.
        Large-scale association analysis identifies 13 new susceptibility loci for coronary artery disease.
        Nat. Genet. 2011; 43: 333-338
        • Wild P.S.
        • Zeller T.
        • Schillert A.
        • et al.
        A genome-wide association study identifies LIPA as a susceptibility gene for coronary artery disease.
        Circ. Cardiovasc. Genet. 2011; 4: 403-412
        • Reilly M.P.
        • Li M.
        • He J.
        • et al.
        Identification of ADAMTS7 as a novel locus for coronary atherosclerosis and association of ABO with myocardial infarction in the presence of coronary atherosclerosis: two genome-wide association studies.
        Lancet. 2011; 377: 383-392
        • Davies R.W.
        • Wells G.A.
        • Stewart A.F.
        • et al.
        A genome-wide association study for coronary artery disease identifies a novel susceptibility locus in the major histocompatibility complex.
        Circ. Cardiovasc. Genet. 2012; 5: 217-225
        • Consortium, CD
        • Deloukas P.
        • Kanoni S.
        • et al.
        Large-scale association analysis identifies new risk loci for coronary artery disease.
        Nat. Genet. 2013; 45: 25-33
        • Vaarhorst A.A.
        • Lu Y.
        • Heijmans B.T.
        • et al.
        Literature-based genetic risk scores for coronary heart disease: the Cardiovascular Registry Maastricht (CAREMA) prospective cohort study.
        Circ. Cardiovasc. Genet. 2012; 5: 202-209
        • Hughes M.F.
        • Saarela O.
        • Stritzke J.
        • et al.
        Genetic markers enhance coronary risk prediction in men: the MORGAM prospective cohorts.
        PloS One. 2012; 7: e40922
        • Tikkanen E.
        • Havulinna A.S.
        • Palotie A.
        • et al.
        Genetic risk prediction and a 2-stage risk screening strategy for coronary heart disease.
        Arterioscler. Thrombosis Vasc. Biol. 2013; 33: 2261-2266
        • Glumer C.
        • Jorgensen T.
        • Borch-Johnsen K.
        • et al.
        Prevalences of diabetes and impaired glucose regulation in a Danish population: the Inter99 study.
        Diabetes Care. 2003; 26: 2335-2340
        • Jorgensen T.
        • Borch-Johnsen K.
        • Thomsen T.F.
        • et al.
        A randomized non-pharmacological intervention study for prevention of ischaemic heart disease: baseline results Inter99.
        Eur. J. Cardiovasc Prev. Rehabil. 2003; 10: 377-386
        • Andersen T.F.
        • Madsen M.
        • Jorgensen J.
        • et al.
        The Danish National Hospital Register. A valuable source of data for modern health sciences.
        Dan. Med. Bull. 1999; 46: 263-268
        • Juel K.
        • Helweg-Larsen K.
        The Danish registers of causes of death.
        Dan. Med. Bull. 1999; 46: 354-357
        • Friedewald W.T.
        • Levy R.I.
        • Fredrickson D.S.
        Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge.
        Clin. Chem. 1972; 18: 499-502
        • Varbo A.
        • Benn M.
        • Tybjaerg-Hansen A.
        • et al.
        Remnant cholesterol as a causal risk factor for ischemic heart disease.
        J. Am. Coll. Cardiol. 2013; 61: 427-436
        • Johnson A.D.
        • Handsaker R.E.
        • Pulit S.L.
        • et al.
        SNAP: a web-based tool for identification and annotation of proxy SNPs using HapMap.
        Bioinformatics. 2008; 24: 2938-2939
        • Hivert M.F.
        • Jablonski K.A.
        • Perreault L.
        • et al.
        Updated genetic score based on 34 confirmed type 2 diabetes Loci is associated with diabetes incidence and regression to normoglycemia in the diabetes prevention program.
        Diabetes. 2011; 60: 1340-1348
        • Liu M.
        • Kapadia A.S.
        • Etzel C.J.
        Evaluating a new risk Marker's predictive contribution in survival models.
        J. Stat. Theory Pract. 2010; 4: 845-855
        • Pencina M.J.
        • D'Agostino Sr., R.B.
        • D'Agostino Jr., R.B.
        • et al.
        Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond.
        Stat. Med. 2008; 27 (discussion 207–112): 157-172
        • Manolio T.A.
        • Collins F.S.
        • Cox N.J.
        • et al.
        Finding the missing heritability of complex diseases.
        Nature. 2009; 461: 747-753
        • Kitsios G.D.
        • Dahabreh I.J.
        • Trikalinos T.A.
        • et al.
        Heterogeneity of the phenotypic definition of coronary artery disease and its impact on genetic association studies.
        Circ. Cardiovasc. Genet. 2011; 4: 58-67
        • de Miguel-Yanes J.M.
        • Shrader P.
        • Pencina M.J.
        • et al.
        Genetic risk reclassification for type 2 diabetes by age below or above 50 years using 40 type 2 diabetes risk single nucleotide polymorphisms.
        Diabetes care. 2011; 34: 121-125
        • Ganna A.
        • Magnusson P.K.
        • Pedersen N.L.
        • et al.
        Multilocus Genetic Risk Scores for Coronary Heart Disease Prediction, Arteriosclerosis, Thrombosis, and Vascular Biology.
        2013
        • Kilpelainen T.O.
        • Qi L.
        • Brage S.
        • et al.
        Physical activity attenuates the influence of FTO variants on obesity risk: a meta-analysis of 218,166 adults and 19,268 children.
        PLoS Med. 2011; 8: e1001116
        • Qi Q.
        • Chu A.Y.
        • Kang J.H.
        • et al.
        Sugar-sweetened beverages and genetic risk of obesity.
        N. Engl. J. Med. 2012; 367: 1387-1396
        • Madsen M.
        • Davidsen M.
        • Rasmussen S.
        • et al.
        The validity of the diagnosis of acute myocardial infarction in routine statistics: a comparison of mortality and hospital discharge data with the Danish MONICA registry.
        J. Clin. Epidemiol. 2003; 56: 124-130
        • Lidegaard O.
        • Vestergaard C.H.
        • Hammerum M.S.
        Quality monitoring based on data from the Danish National Patient Registry.
        Ugeskr. Laeger. 2009; 171: 412-415
        • Dudbridge F.
        Power and predictive accuracy of polygenic risk scores.
        PLoS Genet. 2013; 9: e1003348
        • Chatterjee N.
        • Wheeler B.
        • Sampson J.
        • et al.
        Projecting the performance of risk prediction based on polygenic analyses of genome-wide association studies.
        Nat. Genet. 2013; 45 (405e401-403): 400-405
        • Soininen P.
        • Kangas A.J.
        • Wurtz P.
        • et al.
        High-throughput serum NMR metabonomics for cost-effective holistic studies on systemic metabolism.
        Analyst. 2009; 134: 1781-1785
        • Cohen J.C.
        • Boerwinkle E.
        • Mosley Jr., T.H.
        • et al.
        Sequence variations in PCSK9, low LDL, and protection against coronary heart disease.
        N. Engl. J. Med. 2006; 354: 1264-1272